Alzheimer's disease as a neurodegenerative manifestation of type 2 diabetes

Authors

  • Rocío Soledad Meza Maceiras Universidad Abierta Interamericana, Facultad de Medicina y Ciencias de la Salud, Carrera de Medicina. Buenos Aires, Argentina. Author
  • Karina Bustamante Galarza Universidad Abierta Interamericana, Facultad de Medicina y Ciencias de la Salud, Carrera de Medicina. Buenos Aires, Argentina. Author

DOI:

https://doi.org/10.56294/shp2025204

Keywords:

Diabetes Mellitus, Alzheimer's, neurodegeneration, insulin resistance, treatment

Abstract

The research addressed the relationship between Type 2 Diabetes Mellitus (DM2) and Alzheimer's disease, two pathologies of high prevalence and impact. Although traditionally considered independent diseases, they were shown to share common pathophysiological mechanisms such as insulin resistance, oxidative stress and chronic inflammation. Scientific evidence allowed the hypothesis of Alzheimer's as a possible ‘type 3 diabetes’ to be proposed, highlighting the implication of genetic factors, such as the ε4 allele of the APOE gene. In addition, antidiabetic therapies with neuroprotective potential, such as intranasal insulin and metformin, were analysed. This complex and multifactorial relationship offered new therapeutic and preventive perspectives for both diseases, especially in older adults.

References

1. Ott RS, A. The Rotterdam Study. Neurology. 1951.

2. American Diabetes Association. Diagnosis and Classification of Diabetes Mellitus. Diabetes Care. 2014 Jan 14;37(Suppl 1):S81–9.

3. Asociación Americana de Diabetes. 2004.

4. Ciudin A. Diabetes Mellitus tipo II y Alzheimer: Una relación para no olvidar. Endocrinol Nutr.

5. Domínguez RO, P.M. Enfermedad de Alzheimer y deterioro cognitivo asociado a la diabetes mellitus de tipo 2: relaciones e hipótesis.

6. Donoso A. La enfermedad de Alzheimer y otras demencias. Santiago de Chile: Universitaria; s.f.

7. Formiga F, Reñe R, Perez Maraver M. Demencia y diabetes: ¿relación causal o casual? 2014.

8. Gii-Velázquez LE, Sii-Acosta MJ, Domínguez-Sánchez ER, Torres-Arreola Ld, Medina-Chávez JH. Diagnóstico y Tratamiento de la Diabetes Mellitus tipo 2.

9. Infante Garcia C, Moya M, Garcia Alloza M. Enfermedad de Alzheimer y Diabetes Mellitus Tipo II.

10. Lladó Plarrumaní A, Falgas Martínez N, Barreiro Gigan S, Sanchez del Valle Díaz R. Clinic Barcelona [Internet]. 2018 Apr [citado 2025 Abr 3]. Disponible en: https://www.clinicbarcelona.org/asistencia/enfermedades/alzheimer/causas-y-factores-de-riesgo

11. Luchsinger J. Diabetes, related conditions, and dementia. J Neurol Sci. 2010.

12. Rita P, Beatriz R, Lenore L. Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies. 2002.

13. Solis DG. Una nueva etapa en el diagnóstico de la enfermedad de Alzheimer. 2018.

14. Voto L, Nicolotti A, Salcedo L, Maria GA, Nasiff J, Cremonte Ortiz A. Consenso de diabetes. 2012.

Downloads

Published

2025-05-11

How to Cite

1.
Meza Maceiras RS, Bustamante Galarza K. Alzheimer’s disease as a neurodegenerative manifestation of type 2 diabetes. South Health and Policy [Internet]. 2025 May 11 [cited 2025 Aug. 19];4:204. Available from: https://shp.ageditor.ar/index.php/shp/article/view/204